January 10, 2022 at 03:16PM Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act
This guidance clarifies who should notify, what information to include, and how to notify FDA of shortages, during or in advance of a public health emergency
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3neCJMl
No comments:
Post a Comment